Epigenetic inactivation of the MIR129-2 in hematological malignancies
Epigenetic inactivation of the MIR129-2 in hematological malignancies
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
MIR129-2 has been shown to be a tumor suppressor microRNA hypermethylated in epithelial cancers.
Epigenetic inactivation of MIR129-2 was studied by methylation-specific PCR (MSP) in 13 cell lines (eight myeloma and five lymphoma), 15 normal controls and 344 primary samples including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL...
Alternative Titles
Full title
Epigenetic inactivation of the MIR129-2 in hematological malignancies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f0e7309b82eb41dcb4aaf3ed0523d7e6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f0e7309b82eb41dcb4aaf3ed0523d7e6
Other Identifiers
ISSN
1756-8722
E-ISSN
1756-8722
DOI
10.1186/1756-8722-6-16
